MemoryGuardTM contains per serving 150 mg Ginkgo biloba Extract, thus considered as safe and can be administered alone or in combination with oral anticoagulants. Its unique combination of Omega-3 DHA, Ginkgo biloba Extract, CoQ10, and Vitamin E make this one of the most efficient “brain foods” on the market.
Daily supplementation of 1000mg to 2000mg Omega-3 (DHA and EPA) may be an efficient way to support your body to prevent or decrease an excessive inflammatory response when suffering from a Covid-19 or any other inflammatory condition. To enable its entire range of protective activities, both EPA and or DHA supplementation should be ongoing for at least 4 -6 weeks before the first symptoms show up
An intent to help understand the outcome of the STRENGTH Trial showing no significant reduction in cardiovascular risk after 12 months supplementation of 4 g per day EPA+DHA in the free fatty acid (FFA) form. Was the initial EPA+DHA level in the Treatment Group so high to start with, that the additional protection effect coming from the omega-3 drug was possibly not statistically detectable? Study data seem to indicate this direction. Also, considering the high daily dose of omega-3 FFA and the duration of the trial, the recorded increase in EPA+DHA levels in the plasma of the subjects (from 6.9 to 9.4 µg/dl) seems low. Is it possible that there might have been an absorption problem due to a very late release of the omega-3 fatty acids from the special enteric-coated soft gels?
MemoryGuardTM contains per serving 150 mg Ginkgo biloba Extract, thus considered as safe and can be administered alone or in combination with oral anticoagulants. Its unique combination of Omega-3 DHA, Ginkgo biloba Extract, CoQ10, and Vitamin E make this one of the most efficient “brain foods” on the market.
Daily supplementation of 1000mg to 2000mg Omega-3 (DHA and EPA) may be an efficient way to support your body to prevent or decrease an excessive inflammatory response when suffering from a Covid-19 or any other inflammatory condition. To enable its entire range of protective activities, both EPA and or DHA supplementation should be ongoing for at least 4 -6 weeks before the first symptoms show up
An intent to help understand the outcome of the STRENGTH Trial showing no significant reduction in cardiovascular risk after 12 months supplementation of 4 g per day EPA+DHA in the free fatty acid (FFA) form. Was the initial EPA+DHA level in the Treatment Group so high to start with, that the additional protection effect coming from the omega-3 drug was possibly not statistically detectable? Study data seem to indicate this direction. Also, considering the high daily dose of omega-3 FFA and the duration of the trial, the recorded increase in EPA+DHA levels in the plasma of the subjects (from 6.9 to 9.4 µg/dl) seems low. Is it possible that there might have been an absorption problem due to a very late release of the omega-3 fatty acids from the special enteric-coated soft gels?
by: Peter Lembke, VitalremedyMD Inc, Boca Raton, FL (copyright) February 10th, 2021 Summary An ideal omega-3 supplement should contain highly con...
OMEGA-3 PUEDE AYUDAR A REDUCIR LA INTENSIDAD DE UNA RESPUESTA INFLAMATORIA ("TORMENTA DE CITOQUINAS") Omega-3 (EPA, DPA, DHA) ayudan a controlar...
